Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/1996
05/08/1996EP0710235A1 Endothelin antagonists
05/08/1996EP0710233A1 Heteroaryl cycloalkenyl hydroxyureas
05/08/1996EP0710227A1 Vitamin d analogues
05/08/1996EP0710109A1 Compounds
05/08/1996EP0710107A1 N,n,n-trimethylsphingosine derivatives
05/08/1996CN1121826A "Fukangling" medicine for treatment of gynecopathy
05/07/1996US5514716 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
05/07/1996US5514702 Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory activity
05/07/1996US5514699 Pharmaceutical compounds
05/07/1996US5514687 Benzopyrido piperidylidene compounds, compositions, methods of manufacture and method of use
05/07/1996US5514685 Antiinflammatory antoproliferative agents, immunosuppressants
05/07/1996US5514677 Hydroxamic acid based collagenase inhibitors
05/07/1996US5514661 Autoimmune disease treatment
05/07/1996US5514555 Assays and therapeutic methods based on lymphocyte chemoattractants
05/07/1996CA2099565C N-hydroxyurea derivatives as antiallergy and antiinflammatory agents
05/07/1996CA2075551C Treatment of periodontitis
05/07/1996CA1338309C Homologues of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
05/02/1996WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996WO1996012741A1 Binding agents to cd23
05/02/1996WO1996012735A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding
05/02/1996WO1996012727A1 Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer
05/02/1996WO1996012720A1 Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
05/02/1996WO1996012710A1 Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents
05/02/1996WO1996012499A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes
05/02/1996WO1996012491A1 Method of inhibiting conditions associated with bradykinin
05/02/1996CA2203914A1 Method of inhibiting conditions associated with bradykinin
05/02/1996CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996CA2203363A1 Binding agents to cd23
05/01/1996EP0709383A1 Diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them
05/01/1996EP0709375A2 Therapeutic heterocycles
05/01/1996EP0708778A1 Imidazo[1,2-a]pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists
05/01/1996EP0708774A1 Imidazo [1,2-a]pyrazine-4-one, preparation thereof and drugs containing same
05/01/1996EP0708771A1 Benzyloxyquinuclidines as substance p antagonists
05/01/1996EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties
05/01/1996EP0708766A1 Use of coumarins as pla 2-inhibitors, new coumarins, process for preparing the same and medicaments
05/01/1996EP0708755A1 Novel vitamin d analogues
05/01/1996EP0708651A1 Therapeutic agent
05/01/1996EP0708648A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
05/01/1996CN1121717A Heterocyclic compounds and their preparation and use
05/01/1996CN1121715A 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors
05/01/1996CN1121430A Inmunization adjusting, anti-inflamation agent
04/1996
04/30/1996US5512594 Administering to treat a medical condition mediated by one or more leukotrienes
04/30/1996US5512576 2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
04/30/1996US5512570 Treatment of emesis with morpholine tachykinin receptor antagonists
04/30/1996US5512568 For treating a mammal having a disease state that is alleviated by treatment with an inosine 5'-monophosphate dehydrogenase inhibitor
04/30/1996US5512552 Bone resorption inhibitor; osteoporosis
04/30/1996US5512302 Pharmaceutical process using starch
04/30/1996CA1338287C Hetrazepines and processes for preparing them
04/25/1996WO1996012022A1 Intracellular isoform of the interleukin-1 receptor antagonist
04/25/1996WO1996011950A1 Method of treating diabetes mellitus using kgf
04/25/1996WO1996011949A2 Analogs of keratinocyte growth factor
04/25/1996WO1996011933A1 Fused pyrrolocarbazoles
04/25/1996WO1996011925A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists
04/25/1996WO1996011920A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists
04/25/1996WO1996011911A1 5-lipoxygenase inhibitors
04/25/1996WO1996011908A1 Modified polyunsaturated fatty acids
04/25/1996WO1996011902A1 Pharmaceutically active substituted aromatic compounds
04/25/1996WO1996011690A1 Diazepino-indoles as phosphodiesterase iv inhibitors
04/25/1996WO1996011685A2 Use of indole derivatives for the treatment of various diseases
04/25/1996CA2202056A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists
04/25/1996CA2201742A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists
04/25/1996CA2200628A1 Diazepino-indoles as phosphodiesterase iv inhibitors
04/24/1996EP0708111A1 17-Desoxy corticosteroid-21-esters, a process for their preparation and pharmaceutical compositions containing them
04/24/1996EP0708101A1 Novel piperidine derivatives, useful as neurokinin receptor antagonists
04/24/1996EP0707849A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
04/24/1996EP0707847A1 Ketoprofen liposomes
04/24/1996EP0707566A1 Novel structural analogues of vitamin d
04/24/1996EP0707495A1 Compositions for treating hypoxia-associated ocular complications
04/24/1996EP0489070B1 Novel inhibitors of thrombin
04/24/1996CN1121074A Novel N-pyridyl carboxamides and derivatives, processes for their preparation and the pharmaceutical compositions which contain them
04/24/1996CN1031618C Process for preparing mixture with N-aminoalkyl-aza-spiro alkane derivatives as its active composition
04/23/1996US5510385 Analgesics, antiinflammatory agents
04/23/1996US5510382 Administering prostaglandin e derivatives
04/23/1996US5510361 Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents
04/23/1996US5510333 Inhibitors of Cathepsin G and elastase for preventing connective tissue degradation
04/21/1996CA2160739A1 Ketoprofen liposomes
04/18/1996WO1996011271A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
04/18/1996WO1996011269A2 Tie-2 ligands, methods of making and uses thereof
04/18/1996WO1996011209A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
04/18/1996WO1996011200A1 Purine and guanine compounds as inhibitors of pnp
04/18/1996WO1996011199A1 Naphthyridinone derivatives
04/18/1996WO1996011198A1 Naphthyridine derivatives
04/18/1996WO1996011192A1 Lta4 hydrolase inhibitors
04/18/1996WO1996011184A1 Colchicine derivatives and the therapeutical use thereof
04/18/1996WO1996011020A1 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient
04/18/1996WO1996010999A2 Lta4 hydrolase inhibitor pharmaceutical compositions and methods of use
04/18/1996WO1996010912A1 Method for reducing unwanted cellular adhesions
04/18/1996WO1996007739A3 Interleukin-1 type 3 receptors
04/18/1996CA2202371A1 Lta4 hydrolase inhibitors
04/18/1996CA2202368A1 Lta4 hydrolase inhibitor pharmaceutical compositions and methods of use
04/18/1996CA2201773A1 Purine and guanine compounds as inhibitors of pnp
04/18/1996CA2201639A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
04/17/1996EP0707006A1 Aroyl-piperidine derivatives
04/17/1996EP0707004A1 1-Arylalcenyl 4-arylmethylpiperazinderivatives, process for their preparation and pharmaceutical composition containing them
04/17/1996EP0706797A2 Compositions containing carbohydrates obtained from plants of the family cactacea
04/17/1996EP0706795A2 Catechol diether compounds as inhibitors of TNF release
04/17/1996EP0706657A1 Inhibiting protein interactions
04/17/1996EP0706564A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods
04/17/1996EP0706395A1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
04/17/1996EP0706394A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
1 ... 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 ... 1272